160 related articles for article (PubMed ID: 29894425)
1. Lenvatinib-Induced Acute Pancreatitis Associated With a Pancreatic Pseudocyst and Splenic Pseudoaneurysms.
Kawakami H; Kubota Y; Ban T; Shibata N; Hosokawa A
Pancreas; 2018 Jul; 47(6):e34-e35. PubMed ID: 29894425
[No Abstract] [Full Text] [Related]
2. [Lenvatinib in radioiodine refractory thyroid carcinomas].
de la Fouchardiere C
Bull Cancer; 2016 Nov; 103(11):905-910. PubMed ID: 27817859
[TBL] [Abstract][Full Text] [Related]
3. Lenvatinib improves survival in refractory thyroid cancer.
Mayor S
Lancet Oncol; 2015 Mar; 16(3):e110. PubMed ID: 25683848
[No Abstract] [Full Text] [Related]
4. Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with 'untargeted' side effects.
Berends AMA; van der Horst-Schrivers ANA; Oosting SF; Kapiteijn EW; de Groot JWB; Links TP
Acta Oncol; 2020 Jun; 59(6):726-729. PubMed ID: 32056474
[No Abstract] [Full Text] [Related]
5. Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer.
Hewett Y; Ghimire S; Farooqi B; Shah BK
J Oncol Pharm Pract; 2018 Jan; 24(1):28-32. PubMed ID: 27856921
[TBL] [Abstract][Full Text] [Related]
6. [Pseudoaneurysms associated with a "retention" pseudocyst in chronic pancreatitis].
Castellote JM; Luengo L; Gómez JR; Ros S; Feliu F; Vicente V
Rev Esp Enferm Dig; 1995 Jul; 87(7):548-9. PubMed ID: 7662426
[No Abstract] [Full Text] [Related]
7. Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib.
Danilovic DL; de Camargo RY; Castro G; Papadia C; Marui S; Hoff AO
Thyroid; 2015 Nov; 25(11):1262-4. PubMed ID: 26357945
[No Abstract] [Full Text] [Related]
8. [Upper gastrointestinal hemorrhage associated with chronic pancreatitis and pseudocyst: report of a case].
Nogara MA; Cesar AM; Kanegusuku J; Lopes RW
Arq Gastroenterol; 1993; 30(1):33-7. PubMed ID: 8240062
[TBL] [Abstract][Full Text] [Related]
9. Pseudoaneurysm of the radial branch of the splenic artery with pancreatic pseudocyst in a child with recurrent acute pancreatitis: treatment with endovascular stent graft and cystogastrostomy.
Puri A; Acharya H; Tyagi S; Curian S; Chadha R; Anand R; Choudhary SR
J Pediatr Surg; 2012 May; 47(5):1012-5. PubMed ID: 22595592
[TBL] [Abstract][Full Text] [Related]
10. Lenvatinib: Role in thyroid cancer and other solid tumors.
Cabanillas ME; Habra MA
Cancer Treat Rev; 2016 Jan; 42():47-55. PubMed ID: 26678514
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancer.
Date E; Okamoto K; Fumita S; Kaneda H
Invest New Drugs; 2018 Apr; 36(2):350-353. PubMed ID: 29018997
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Lenvatinib, Sorafenib and Placebo in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer.
Wilson L; Huang W; Chen L; Ting J; Cao V
Thyroid; 2017 Aug; 27(8):1043-1052. PubMed ID: 28486081
[TBL] [Abstract][Full Text] [Related]
13. Lenvatinib in radioiodine-refractory thyroid cancer.
Lee HJ; Yun HJ; Kim S
N Engl J Med; 2015 May; 372(19):1868. PubMed ID: 25946296
[No Abstract] [Full Text] [Related]
14. Lenvatinib in radioiodine-refractory thyroid cancer.
Schlumberger M; Tahara M; Wirth LJ
N Engl J Med; 2015 May; 372(19):1868. PubMed ID: 25946295
[No Abstract] [Full Text] [Related]
15. Drug safety evaluation of lenvatinib for thyroid cancer.
Krajewska J; Kukulska A; Jarzab B
Expert Opin Drug Saf; 2015; 14(12):1935-43. PubMed ID: 26484847
[TBL] [Abstract][Full Text] [Related]
16. Therapy: Lenvatinib and radioiodine-refractory thyroid cancers.
Dunn L; Fagin JA
Nat Rev Endocrinol; 2015 Jun; 11(6):325-7. PubMed ID: 25824678
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine cancer: SELECT—lenvatinib in thyroid cancer.
Killock D
Nat Rev Clin Oncol; 2015 Apr; 12(4):189. PubMed ID: 25707627
[No Abstract] [Full Text] [Related]
18. Progressive abdominal pain after acute pancreatitis.
Chang LC; Liu KL; Wang HP
Gut; 2011 Jul; 60(7):922, 976. PubMed ID: 20542861
[No Abstract] [Full Text] [Related]
19. Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer.
Cabanillas ME; Takahashi S
Semin Oncol; 2019 Feb; 46(1):57-64. PubMed ID: 30685073
[TBL] [Abstract][Full Text] [Related]
20. Lenvatinib: first global approval.
Scott LJ
Drugs; 2015 Apr; 75(5):553-60. PubMed ID: 25795101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
